|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, said it broadened its alliance with Baxter Healthcare Corp., of Deerfield, Ill., giving Baxter the right to manufacture CoSeal, a surgical sealant, and Adhibit, a surgical anti-adhesive. Angiotech got the products through its acquisition of Cohesion Technologies Inc. in September. In February, Angiotech gave Baxter worldwide (excluding Japan and certain other territories) sales, marketing and distribution rights for CoSeal and Adhibit for total potential compensation of C$34 million (US$15.1 million). (See BioWorld Today, Oct. 1, 2002.)
o Diversified Biotech Holdings Corp., of New York, raised $3.2 ...